Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

{"article_title":"Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.","author":"Pathirana J, Mu\u00f1oz FM, Abbing-Karahagopian V, Bhat N, Harris T, Kapoor A, Keene DL, Mangili A, Padula MA, Pande SL, Pool V, Pourmalek F, Varricchio F, Kochhar S, Cutland CL","journal_title":"Vaccine","issn":"1873-2518","isbn":"","publication_date":"2016-12-01","volume":"34","issue":"49","first_page":"6027","page_count":"","accession_number":"27449077","doi":"10.1016\/j.vaccine.2016.03.040","publisher":"Elsevier Science","doctype":"Guideline","subjects":"Data Collection; Infant Mortality; Perinatal Death; Vaccines adverse effects; Child; Clinical Trials as Topic; Female; Humans; Immunization adverse effects; Infant; Infant, Newborn; Morbidity; Mothers; Pregnancy; Statistics as Topic; Vaccines administration & dosage","interest_area":["Pediatric Medicine"],"abstract":"More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality. With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death. This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother. Copyright \u00c2\u00a9 2016. Published by Elsevier Ltd.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=27449077","isPdfLink":false,"isSAML":false,"an":"27449077","number_other":"","type_pub":"","issn_electronic":"1873-2518","languages":"English","language":"eng","date_entry":"Date Created: 20160725 Date Completed: 20171204 Latest Revision: 20181113","date_update":"20240104","titleSource":"Vaccine [Vaccine] 2016 Dec 01; Vol. 34 (49), pp. 6027-6037. Date of Electronic Publication: 2016 Jul 19.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2016-12-01","description":"More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality. With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death. This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother.<br \/> (Copyright © 2016. Published by Elsevier Ltd.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=27449077&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Pathirana J, Mu\u00f1oz FM, Abbing-Karahagopian V, Bhat N, Harris T, Kapoor A, Keene DL, Mangili A, Padula MA, Pande SL, Pool V, Pourmalek F, Varricchio F, Kochhar S, Cutland CL"}